Home / Business and Economy / Novonesis CEO Foresees Slow Recovery for Supplements
Novonesis CEO Foresees Slow Recovery for Supplements
5 Nov
Summary
- North American dietary supplement market is experiencing a slowdown.
- US consumer behavior and purchasing power are negatively impacting sales.
- Growth for the supplement market is not expected until late 2027.
The North American dietary supplement market is experiencing a significant downturn, with current conditions expected to persist for some time. Changing consumer behaviors and reduced purchasing power in the United States are identified as key factors contributing to this slowdown.
Novonesis, a biotech firm, reported an 8% decrease in revenue for its Human Health division during the third quarter. This decline was primarily driven by weaker sales of dietary supplements in North America, particularly in offline channels.
CEO Ester Baiget shared these insights during a post-earnings call, expressing that a recovery and return to growth for the North American dietary supplement market are not anticipated until the latter half of 2027. This projection highlights the prolonged impact of current economic factors on the industry.
